MEDBOX | Toolbox Surveillance & Contact tracing

Guidance for surveillance of SARS-CoV-2 variants - Arabic version

World Health Organisation (WHO) (2021) C_WHO

This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators is also provided to standardize monitoring and public reporting of variant circulation. The document is primarily intended for national and sub-national public health authorities and partners who support implementation of surveillance for SARS-CoV-2 variant

Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19,

Source: https://apps.who.int/iris/bitstream/hand

Orientations pour la surveillance des variants du SARS-CoV-2

World Health Organisation (WHO) (2021) C_WHO

Orientations provisoires 9 août 2021 Le présent document vise à décrire un ensemble minimal d'activités de surveillance recommandées au niveau national pour détecter et surveiller la prévalence relative des variantes du SRAS-CoV-2 et à présenter un ensemble d'activités pour la caractérisation et l'évaluation du risque que présentent ces variantes. k posés par ces variants. Un ensemble d'indicateurs est également fourni pour normaliser la surveillance et la déclaration publique de la circulation des variants. Ce document est principalement destiné aux autorités de santé publique nationales et infranationales et aux partenaires qui soutiennent la mise en œuvre de la surveillance des variantes du SRAS-CoV-2

Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19,

Source: https://apps.who.int/iris/bitstream/hand

Руководство по эпидемиологическому надзору за вариантами SARS-CoV-2

World Health Organisation (WHO) (2021) C_WHO

Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19,

Source: https://apps.who.int/iris/bitstream/hand

Orientaciones para la vigilancia de las variantes del SARS-CoV-2

World Health Organisation (WHO) (2021) C_WHO

Orientaciones provisionales 9 de agosto de 2021 El presente documento tiene por objeto describir un conjunto mínimo de actividades de vigilancia recomendadas a nivel nacional para detectar y supervisar la prevalencia relativa de las variantes del SRAS-CoV-2 y esbozar un conjunto de actividades para la caracterización y evaluación del riesgo que plantean estas variantes. También se ofrece un conjunto de indicadores para normalizar la vigilancia y la notificación pública de la circulación de variantes. El documento está dirigido principalmente a las autoridades de salud pública nacionales y subnacionales y a los socios que apoyan la aplicación de la vigilancia de las variantes del SRAS-CoV-

Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19,

Source: https://apps.who.int/iris/bitstream/hand

SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021

Kleynhans, J.; et al. (2021) C_CDC

EID Journal , Volume 27, no.12 , Dec. 2021. Early Release Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated because of limited access to testing. We measured SARS-CoV-2 seroprevalence in South Africa every 2 months during July 2020–March 2021 in randomly selected household cohorts in 2 communities. We compared seroprevalence to reported laboratory-confirmed infections, hospitalizations, and deaths to calculate infection–case, infection–hospitalization, and infection–fatality ratios in 2 waves of infection. Post–second wave seroprevalence ranged from 18% in the rural community children <5 years of age, to 59% in urban community adults 35–59 years of age. The second wave saw a shift in age distribution of case-patients in the urban community (from persons 35–59 years of age to persons at the extremes of age), higher attack rates in the rural community, and a higher infection–fatality ratio in the urban community. Approximately 95% of SARS-CoV-2 infections were not reported to national surveillance

Tags: mortality, excess mortality, COVID-19, South Africa, laboratory-confirmed, Surveillance,

Source: https://wwwnc.cdc.gov/eid/article/27/12/

World Health Organization WHO (2021) CC

Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19,

Source: https://apps.who.int/iris/rest/bitstream

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC

Since the emergence of COVID 19 in December 2019, various public health responses measures have been implemented to control the pandemic. Among measures taken by the Africa CDC was the launch of PACT initiative to accelerate COVID 19 testing. Key to the initiative is the engagement of Community Health Workers (CHWs) in risk communication and community engagement (RCCE), surveillance activities for early case identification, contacts tracing and in facilitating referrals for testing and continuum of care. As of 31 May 2021, Through PACT support, over 17154 CHWs have been trained and locally deployed in 24 AU Member states. The PACT supported CHWs visited more than 2,568,654 households for community engagement activities, active case search and contact tracing, identified 1,618,601 Contacts, 710,167 COVID 19 suspect cases based on the standard case definition and facilitated referrals for 553053 (78%) suspect cases for testing. These efforts were crucial for early identification and isolation of cases in limiting further transmission

Tags: CHW, Community Health Worker (CHW), COVID-19, outbreak management, public health services, case detection,

Source: https://africacdc.org/download/the-criti

World Health Organization WHO (2021) C_WHO

orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommandations relatives aux stratégies nationales de dépistage et à l'utilisation de la PCR et des tests antigéniques rapides dans différents scénarios de transmission de l'épidémie de COVID-19, y compris la manière dont les tests pourraient être rationalisés dans les milieux à faibles ressources. Tous les tests doivent être suivis d'une réponse de santé publique forte, comprenant l'isolement des personnes dont le test est positif et la fourniture de soins, la recherche des contacts et la mise en quarantaine des contacts

Tags: laboratory, Testing, diagnostic, SARS-CoV-2, Surveillance, Outbreak Control, PCR, rapid antigen test, Quarantine,

Source: https://apps.who.int/iris/bitstream/hand

World Health Organization WHO (2021) C_WHO

Over 18 months into the pandemic, WHO continues to conductglobal surveillance of COVID-19as part of activities on preparedness, readiness and response activities. The need for global surveillance of COVID-19 is greater than ever, asthe implementation of vaccination campaigns and the appearance of variants are prone to impact the course of the epidemic, as transmission patterns evolve. Timely and complete surveillance data are key to monitoring these changes. Features include stratification by age and sex, trends over time, case fatality ratios by age, testing, hospitalization, and data on health workers –all visible at country and regional levels. The dashboard provides the ability for users to conduct further analyses by country and selected time period

Tags: dashboard, Surveillance, COVID-19, Analysis, data, database,

Source: https://app.powerbi.com/view?r=eyJrIjoiY

An update on Testing strategies for COVID-19

World Health Organization WHO (2021) C_WHO

9 July 2021

Tags: Public health, Outbreak Control, pandemic Preparedness, Testing, public health measures,

Source: https://www.who.int/docs/default-source/

	Guidance for surveillance of SARS-CoV-2 variants - Arabic version World Health Organisation (WHO) (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators is also provided to standardize monitoring and public reporting of variant circulation. The document is primarily intended for national and sub-national public health authorities and partners who support implementation of surveillance for SARS-CoV-2 variant Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19, Source: https://apps.who.int/iris/bitstream/hand
	Orientations pour la surveillance des variants du SARS-CoV-2 World Health Organisation (WHO) (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX Orientations provisoires 9 août 2021 Le présent document vise à décrire un ensemble minimal d'activités de surveillance recommandées au niveau national pour détecter et surveiller la prévalence relative des variantes du SRAS-CoV-2 et à présenter un ensemble d'activités pour la caractérisation et l'évaluation du risque que présentent ces variantes. k posés par ces variants. Un ensemble d'indicateurs est également fourni pour normaliser la surveillance et la déclaration publique de la circulation des variants. Ce document est principalement destiné aux autorités de santé publique nationales et infranationales et aux partenaires qui soutiennent la mise en œuvre de la surveillance des variantes du SRAS-CoV-2 Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19, Source: https://apps.who.int/iris/bitstream/hand
	Руководство по эпидемиологическому надзору за вариантами SARS-CoV-2 World Health Organisation (WHO) (2021) C_WHO View PDF(1) Download (1) Add to my MEDBOX Временные рекомендации 9 августа 2021 г. Цель данного документа - описать минимальный набор мероприятий по эп��днадзору, рекомендуемых на национальном уровне для выявления и мониторинга относительной распространенности вариантов SARS-CoV-2, и наметить набор мероприятий для характеристики и оценки риска, создаваемого этими вариантами. Также приводится набор показателей для стандартизации мониторинга и публичной отчетности о циркуляции вариантов. Документ предназначен в первую очередь для национальных и субнациональных органов здравоохранения и партнеров, поддерживающих внедрение эпиднадзора за вариантами SARS-CoV-2 Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19, Source: https://apps.who.int/iris/bitstream/hand
	Orientaciones para la vigilancia de las variantes del SARS-CoV-2 World Health Organisation (WHO) (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX Orientaciones provisionales 9 de agosto de 2021 El presente documento tiene por objeto describir un conjunto mínimo de actividades de vigilancia recomendadas a nivel nacional para detectar y supervisar la prevalencia relativa de las variantes del SRAS-CoV-2 y esbozar un conjunto de actividades para la caracterización y evaluación del riesgo que plantean estas variantes. También se ofrece un conjunto de indicadores para normalizar la vigilancia y la notificación pública de la circulación de variantes. El documento está dirigido principalmente a las autoridades de salud pública nacionales y subnacionales y a los socios que apoyan la aplicación de la vigilancia de las variantes del SRAS-CoV- Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19, Source: https://apps.who.int/iris/bitstream/hand
	SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021 Kleynhans, J.; et al. (2021) C_CDC Open external link (48) Add to my MEDBOX EID Journal , Volume 27, no.12 , Dec. 2021. Early Release Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated because of limited access to testing. We measured SARS-CoV-2 seroprevalence in South Africa every 2 months during July 2020–March 2021 in randomly selected household cohorts in 2 communities. We compared seroprevalence to reported laboratory-confirmed infections, hospitalizations, and deaths to calculate infection–case, infection–hospitalization, and infection–fatality ratios in 2 waves of infection. Post–second wave seroprevalence ranged from 18% in the rural community children <5 years of age, to 59% in urban community adults 35–59 years of age. The second wave saw a shift in age distribution of case-patients in the urban community (from persons 35–59 years of age to persons at the extremes of age), higher attack rates in the rural community, and a higher infection–fatality ratio in the urban community. Approximately 95% of SARS-CoV-2 infections were not reported to national surveillance Tags: mortality, excess mortality, COVID-19, South Africa, laboratory-confirmed, Surveillance, Source: https://wwwnc.cdc.gov/eid/article/27/12/
	Guidance for surveillance of SARS-CoV-2 variants: Interim guidance, 9 August 2021 World Health Organization WHO (2021) CC View PDF(3) Download (2) Add to my MEDBOX This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators is also provided to standardize monitoring and public reporting of variant circulation. The document is primarily intended for national and sub-national public health authorities and partners who support implementation of surveillance for SARS-CoV-2 variant Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19, Source: https://apps.who.int/iris/rest/bitstream
	The Critical Role of Community Health Workers in COVID-19 Vaccine Roll Out African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC View PDF(1) Download (1) Add to my MEDBOX Since the emergence of COVID 19 in December 2019, various public health responses measures have been implemented to control the pandemic. Among measures taken by the Africa CDC was the launch of PACT initiative to accelerate COVID 19 testing. Key to the initiative is the engagement of Community Health Workers (CHWs) in risk communication and community engagement (RCCE), surveillance activities for early case identification, contacts tracing and in facilitating referrals for testing and continuum of care. As of 31 May 2021, Through PACT support, over 17154 CHWs have been trained and locally deployed in 24 AU Member states. The PACT supported CHWs visited more than 2,568,654 households for community engagement activities, active case search and contact tracing, identified 1,618,601 Contacts, 710,167 COVID 19 suspect cases based on the standard case definition and facilitated referrals for 553053 (78%) suspect cases for testing. These efforts were crucial for early identification and isolation of cases in limiting further transmission Tags: CHW, Community Health Worker (CHW), COVID-19, outbreak management, public health services, case detection, Source: https://africacdc.org/download/the-criti
	Recommandations pour les stratégies de dépistage et les capacités de diagnostic du SARS-CoV-2 à l’échelle nationale World Health Organization WHO (2021) C_WHO View PDF(1) Download (1) Add to my MEDBOX orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommandations relatives aux stratégies nationales de dépistage et à l'utilisation de la PCR et des tests antigéniques rapides dans différents scénarios de transmission de l'épidémie de COVID-19, y compris la manière dont les tests pourraient être rationalisés dans les milieux à faibles ressources. Tous les tests doivent être suivis d'une réponse de santé publique forte, comprenant l'isolement des personnes dont le test est positif et la fourniture de soins, la recherche des contacts et la mise en quarantaine des contacts Tags: laboratory, Testing, diagnostic, SARS-CoV-2, Surveillance, Outbreak Control, PCR, rapid antigen test, Quarantine, Source: https://apps.who.int/iris/bitstream/hand
	WHO COVID-19 Detailled Surveillance Data Dashboard World Health Organization WHO (2021) C_WHO Open external link (85) Add to my MEDBOX Over 18 months into the pandemic, WHO continues to conductglobal surveillance of COVID-19as part of activities on preparedness, readiness and response activities. The need for global surveillance of COVID-19 is greater than ever, asthe implementation of vaccination campaigns and the appearance of variants are prone to impact the course of the epidemic, as transmission patterns evolve. Timely and complete surveillance data are key to monitoring these changes. Features include stratification by age and sex, trends over time, case fatality ratios by age, testing, hospitalization, and data on health workers –all visible at country and regional levels. The dashboard provides the ability for users to conduct further analyses by country and selected time period Tags: dashboard, Surveillance, COVID-19, Analysis, data, database, Source: https://app.powerbi.com/view?r=eyJrIjoiY
	An update on Testing strategies for COVID-19 World Health Organization WHO (2021) C_WHO View PDF(2) Download (2) Add to my MEDBOX 9 July 2021 Tags: Public health, Outbreak Control, pandemic Preparedness, Testing, public health measures, Source: https://www.who.int/docs/default-source/

About MEDBOX

MEDBOX Video Series